¼¼°è ÀÇ·á ¹× ÀǾàǰ¿ë ÆÄ¿ìÄ¡ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È 5.4%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- Á¦¾à ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀ¸·Î ¾à¹°Àü´Þ ¸ÞÄ¿´ÏÁò°ú ÈÇÐ ¼ººÐÀÌ ºü¸£°Ô º¯ÈÇϰí ÀÖ½À´Ï´Ù. »õ·Î¿î ¾à¹°Àü´Þ ±â¼úÀÇ ÀûÀýÇÑ ÀÛµ¿°ú º¸È£¸¦ º¸ÀåÇϱâ À§ÇØ º¸´Ù Áøº¸µÇ°í Çö´ëÀûÀÎ ÆÐŰ¡ÀÌ ÇÊ¿äÇÕ´Ï´Ù.
- ¶ÇÇÑ, ÀǾàǰ ÆÄ¿ìÄ¡´Â ÃֽŠ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡¼ ³Î¸® »ç¿ëµÇ´Â Æ÷ÀåÀÇ ÀÏÁ¾ÀÔ´Ï´Ù. ÀǾàǰ ÆÄ¿ìÄ¡´Â ¿ÜºÎ ȯ°æ¿¡ ´ëÇÑ Â÷´Ü¼º ¿Ü¿¡µµ ¼Ò¾Æ ¹× ³ë¾àÀÚ¸¦ À§ÇÑ ¸ð¾ç°ú ¸ÞÄ¿´ÏÁòÀÌ ÀÖ½À´Ï´Ù.
- ÆÄ¿ìÄ¡´Â ÆÇ¸ÅµÇ´Â ¼ÒÇü-ÁßÇüÀÇ ¿¬Áú, ¹Ý¿¬Áú ¹«±Õ ÀÇ·á¿ëǰ¿¡ ¸¹ÀÌ »ç¿ëµÇ´Â ¿ë±â·Î, ¹è¼Û ¹× º¸°ü ½Ã ¼Õ»óÀÌ Àû°í, ¹«±Õ»óÅ·Πº¸°üÇÒ ¼ö ÀÖ½À´Ï´Ù. ±× ¿ëµµ¿¡´Â Á¤¸Æ ³» Ä«Å×ÅÍ, Á¤¸Æ ³» Åõ¿© ¼¼Æ®, Åõ¼®¿ë µð½ºÄ¿³ØÆ® ĸ, »óó µå·¹½Ì, ¼ÒÇü ¼ö¼ú±â±¸, Áø´Ü¿ë °Ë»ç ÆÑ, ºÀÇÕ»ç, Ä¡°ú ¿ëǰ µîÀÌ Æ÷ÇԵ˴ϴÙ.
- Á¦¾à ºÎ¹®Àº Á¦³×¸¯ ÀǾàǰ Á¦Á¶¿¡¼ ½Å¾à °³¹ß·Î ÀüȯÇÏ¿© ½ÃÀå¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. °Ç° Áß±¹ 2030 ±¸»óÀº ÀÌ·¯ÇÑ ÀüȯÀ» °Á¶Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼ Á¦¾à »ê¾÷ÀÇ ¼ºÀåÀº ±âȸ¸¦ âÃâÇϰí ÀÇ·á ¹× ÀǾàǰ ÆÄ¿ìÄ¡ ½ÃÀåÀÇ ¼ºÀåÀ» Àû±ØÀûÀ¸·Î ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÇ·á ¹× ÀǾàǰ¿ë ÆÄ¿ìÄ¡ ½ÃÀå µ¿Çâ
ÇコÄɾî¿Í Á¦¾àÀÇ ¼ºÀå¼¼°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀÔ´Ï´Ù.
- Æú¸®¿¡Æ¿·» ½ÃÀåÀº Áõ°¡ Ãß¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ´Â ÇÃ¶ó½ºÆ½ ÆÄ¿ìÄ¡¸¦ Æ÷ÇÔÇÑ Æú¸®¿¡Æ¿·» Á¦Ç° ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. Æú¸®¿¡Æ¿·»Àº ÀϹÝÀûÀ¸·Î Æú¸®Åº ¶Ç´Â Æú¸®¿¡Æ¿·»À¸·Î ¾Ë·ÁÁø Æú¸®¿¡Æ¿·»Àº ±ä ¿¡Æ¿·» ´Ü·®Ã¼ »ç½½·Î ±¸¼ºµÈ Æú¸®¿Ã·¹ÇÉ ¼öÁö·Î Æú¸®¿Ã·¹ÇÉ ¼öÁö¿¡ ¼ÓÇÕ´Ï´Ù. Æú¸®¿Ã·¹ÇÉ ¼öÁö¿¡ ¼ÓÇÕ´Ï´Ù. ³ôÀº Ãæ°Ý °µµ, °ÇÑ ³»ÈÇмº, ³ôÀº ¿¬¼º, °æ·® µî Æú¸®¿¡Æ¿·»ÀÇ ÀåÁ¡Àº ÀÌ »ê¾÷À» ¹ßÀü½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- »ýºÐÇØ¼º Æú¸®¿¡Æ¿·»ÀÇ ±Þ°ÝÇÑ Áõ°¡´Â ȯ°æ ¹®Á¦¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í Á¤ºÎÀÇ ±ÔÁ¦ °È·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Æú¸®¿¡Æ¿·» ½ÃÀå¿¡ »õ·Î¿î ¼ºÀå Àü¸ÁÀ» °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ÀçȰ¿ë ÇÃ¶ó½ºÆ½À» »ç¿ëÇÏ´Â Çõ½ÅÀûÀÎ ¹æ¹ýÀÇ ÃâÇöÀº Æú¸®¿¡Æ¿·» ½ÃÀåÀÇ ¼ºÀåÀ» È¿°úÀûÀ¸·Î ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.
- ¶ÇÇÑ, ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº Cfr title 21 880.6850¿¡ µû¶ó ÀÇ·á¿ëÀ¸·Î »ç¿ëµÇ´Â ¸ê±Õ Æ÷ÀåÀ» ±ÔÁ¦Çϰí ÀÖÀ¸¸ç, Class II ÀÇ·á±â±â·Î ºÐ·ùÇϰí ÀÖ½À´Ï´Ù. Á¦Á¶¾÷ü´Â Á¦Ç°À» ÆÇ¸ÅÇϱâ À§ÇØ ¹ë¸®µ¥ÀÌ¼Ç Å×½ºÆ®¿Í ±× °á°ú¸¦ ¿ä¾àÇÑ A 510(k)¸¦ Á¦ÃâÇØ¾ß ÇÕ´Ï´Ù. ±ÔÁ¤ Áؼö¿¡ µû¶ó ¹Ì±¹¿¡¼´Â ÆÄ¿ìÄ¡ ½ÃÀåÀÇ ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÏ´Â Ãß¼¼ÀÔ´Ï´Ù.
- Á¦¾à¿ë ÆÄ¿ìÄ¡´Â ¿©·¯ °¡Áö ÀåÁ¡À¸·Î ÀÎÇØ ¾÷°è¿¡¼ ÀαⰡ ³ô¾ÆÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ÆÄ¿ìÄ¡´Â À¯ÇØÇÑ ±¤¼±À̳ª ȯ°æÀ¸·ÎºÎÅÍ ÀǾàǰÀ» º¸È£ÇÒ ¼ö ÀÖ°í, ó¹æÀüÀ» °¢ÀÎÇÒ ¼ö Àֱ⠶§¹®¿¡ Á¦¾à ȸ»çµéÀÌ ¼±È£Çϰí ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀÌ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»ó
- ¾Æ½Ã¾ÆÅÂÆò¾ç ÀǾàǰ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¦¾à Æ÷ÀåÀº Àü ¼¼°èÀûÀ¸·Î Áö¼ÓÀûÀ¸·Î ¹ßÀüÇϰí ÀÖ´Â Á¦¾à »ê¾÷¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀǾàǰ Æ÷ÀåÀº Àεµ, Áß±¹ µî Àα¸ ¹ÐÁý Áö¿ª¿¡¼ ³ôÀº ¼ö¿ä¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌµé ±¹°¡ÀÇ ÀǾàǰ »ý»ê·® Áõ°¡·Î ÀÎÇØ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
- ÀÌ Áö¿ªÀº Áß±¹, Àεµ µî Á¦¾à ¾÷°èÀÇ ÁÖ¿ä ±â¾÷µé·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç, Á¦¾à ¾÷°èÀÇ Àú¸íÇÑ °ø±Þ¾÷ü·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. Àεµ °æÁ¦ ¿¬±¸ 2021¿¡ µû¸£¸é, ÀÚ±¹ ½ÃÀåÀº ÇâÈÄ 10³â°£ 3¹è ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2021³â Àεµ ±¹³» ÀǾàǰ ½ÃÀå ±Ô¸ð´Â 420¾ï ´Þ·¯, 2024³â 650¾ï ´Þ·¯, 2030³â 1,200-1,300¾ï ´Þ·¯·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- ¿¹Ãø ±â°£ µ¿¾È Áö¼Ó°¡´ÉÇÑ Æ÷Àå, ³»±¸¼º, ÀçȰ¿ë °¡´É¼º, º´¿ø ¹× Á¦¾à Á¦Á¶¾÷ü¿Í °°Àº ´Ù¾çÇÑ ÃÖÁ¾»ç¿ëÀÚÀÇ Áõ°¡ Ãß¼¼´Â ÆÄ¿ìÄ¡ »ç¿ëÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °ø±Þ¸Á Áß´ÜÀ¸·Î ÀÎÇØ Çʼö ÀǾàǰ ¿ø·áÀÇ °¡°ÝÀÌ »ó½ÂÇÏ°í ´Ù¾çÇÑ Á¦Ç° À¯ÇüÀÇ ºñ¿ëÀÌ »ó½ÂÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- ±¹³»¿¡¼ »ý»êµÇ´Â ÀǾàǰÀÇ Ç°Áú°ú ¹«°á¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ¾ö°ÝÇÑ ¹ý·üÀÌ µµÀԵʿ¡ µû¶ó ÀǾàǰ Æ÷Àå ¼Ö·ç¼Ç¿¡ À¯¸® »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾÷°è¿¡¼ ¹«±Õ ÀÇ·á¿ë Æ÷Àå Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÇ·á ¹× ÀǾàǰ¿ë ÆÄ¿ìÄ¡ »ê¾÷ °³¿ä
¼¼°è ÀÇ·á ¹× Á¦¾à¿ë ÆÄ¿ìÄ¡ ½ÃÀåÀº °æÀïÀÌ Ä¡¿Çϸç, Áö¿ª ¹× ¼¼°è Ç÷¹À̾ ´Ù¼ö Á¸ÀçÇÕ´Ï´Ù. ÁÖ¿ä ¾÷ü·Î´Â ProAmpac, Glenroy, Inc., Nelipak Corporation, Oliver, Amcor Plc µîÀÌ ÀÖ½À´Ï´Ù.
- 2022³â 6¿ù - Med-tech Innovation Expo¿¡¼ ÆÄ¿ìÄ¡, ¶Ñ²±, ·Ñ ½ºÅå, Ŭ¸° ÄÆ ¸¶¿îÆ® µîÀÇ ÁÖ¿ä °ø±Þ¾÷üÀÎ Oliver Healthcare PackagingÀº Çõ½ÅÀûÀÎ Á¦Ç°À» ½Ã¿¬Çß½À´Ï´Ù. ¸ê±Õ, ¿î¼Û ¹× º¸°ü ÀÛ¾÷¿¡¼ ÀÌ È¸»çÀÇ Æ÷ÀåÀº ÀÇ·á±â±â ¹× ÀǾàǰÀ» º¸È£ÇÕ´Ï´Ù.
- 2021³â 6¿ù - Amcor´Â À¯·´¿¡¼ ÃÖÃÊ·Î ÀǾàǰ°ú ÀÇ·á±â±â Á¶ÇÕ Ç°¸ñÀ» À§ÇÑ ¸ÖƼ è¹ö ÆÄ¿ìÄ¡¸¦ Ãâ½ÃÇÏ¿© ÀÌ¹Ì Flexible Packaging AssociationÀ¸·ÎºÎÅÍ ±â¼ú Çõ½Å ¹× Àç·á ±¸Á¶·Î 2021³â »óÀ» ¼ö»óÇÑ ¹Ù ÀÖ½À´Ï´Ù.
±âŸ ÇýÅÃ
- ¿¢¼¿ Çü½ÄÀÇ ½ÃÀå ¿¹Ãø(ME) ½ÃÆ®
- 3°³¿ù°£ ¾Ö³Î¸®½ºÆ® Áö¿ø
¸ñÂ÷
Á¦1Àå ¼Ò°³
- Á¶»ç »óÁ¤°ú ½ÃÀå Á¤ÀÇ
- Á¶»ç ¹üÀ§
Á¦2Àå Á¶»ç ¹æ¹ý
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå ½ÃÀå ÀλçÀÌÆ®
- ½ÃÀå °³¿ä
- Porter's Five Forces ºÐ¼®
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- ±¸¸ÅÀÚÀÇ ±³¼··Â
- ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
- °æÀï ±â¾÷ °£ÀÇ °æÀï °µµ
- COVID-19ÀÇ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ Æò°¡
Á¦5Àå ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ¼ÒºñÀÚ¿¡ ÀÇÇÑ °æ·® ÆÄ¿ìÄ¡¿¡ ´ëÇÑ ¿ä±¸ »ó½Â
- ÇコÄɾî¿Í ÀǾàǰ¿¡ ´ëÇÑ ÁöÃâ Áõ°¡¿¡ ÀÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø
- ½ÃÀå °úÁ¦
Á¦6Àå ½ÃÀå ¼¼ºÐÈ
- Àç·áº°
- Æú¸®¿¡Æ¿·»
- Æú¸®¿°Èºñ´Ò
- Æú¸®ÇÁ·ÎÇÊ·»
- Æú¸®¿¡Æ¿·» Å×·¹ÇÁÅ»·¹ÀÌÆ®
- ±âŸ Àç·á
- Á¦Ç° À¯Çüº°
- Åë±â¼º ÆÄ¿ìÄ¡
- °³ºÀ ¹æÁö ÆÄ¿ìÄ¡
- ¹Ú¸® ¹æÁö ÆÄ¿ìÄ¡
- ÇÏÀÌ ¹è¸®¾î ÆÄ¿ìÄ¡
- ¿ëµµº°
- Á¤Á¦/ĸ½¶
- ºÐ¸»
- ¾à¹°Àü´Þ ½Ã½ºÅÛ
- Áö¿ªº°
- ºÏ¹Ì
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦7Àå °æÀï ±¸µµ
- ±â¾÷ °³¿ä
- ProAmpac.
- GFR Pharma Ltd
- Glenroy, Inc.
- Nelipak Corporation
- Oliver
- Amcor Plc
- Terrapack
- American FlexPack
Á¦8Àå ÅõÀÚ ºÐ¼®
Á¦9Àå ½ÃÀå Àü¸Á
ksm 25.02.07
The Global Medical & Pharmaceutical Pouch Market is expected to register a CAGR of 5.4% during the forecast period.
Key Highlights
- Pharmaceutical sector technological advancements are rapidly changing the drug delivery mechanism and chemical ingredients. A higher and more modern packaging is required to ensure the appropriate working and protection of the new medication delivery technology.
- Further, Pharmaceutical pouches are one type of packaging widely utilized in modern medication delivery systems. Pharmaceutical pouches are available in child-resistant and senior citizen-friendly forms and mechanisms, in addition to barrier qualities against the external environment.
- Pouches are commonly used containers for small-to-medium-sized soft, semi-soft sterile medical goods sold and are not vulnerable to damage during shipment and storage. The applications include intravenous (IV) catheters, IV administration sets, dialysis disconnect caps, wound dressings, small surgical instruments, diagnostic test packs, sutures, and dental supplies
- The pharmaceutical sector plays a vital role in the market, moving from manufacturing generics to new drug development. The Healthy China 2030 initiative underlines this shift. Hence, the growth of the pharmaceutical industry is expected to create opportunities, thereby driving the medical & pharmaceutical pouch market's growth positively.
Medical & Pharmaceutical Pouch Market Trends
Increasing Growth of Healthcare & Pharmaceutical To Augment The Market Growth
- The polyethylene market witnessed to show an increasing trend. This is due to an increase in demand for polyethylene items including plastic pouches. Polyethylene, commonly known as polythene or polyethylene, is a polyolefin resin made up of long ethylene monomer chains. It belongs to the polyolefin resins family. Polyethylene's advantages, such as higher impact strength, strong chemical resistance, high ductility, and low weight, are projected to propel the industry forward.
- A surge in bio-degradable polyethylene may provide new growth prospects for the polyethylene market throughout the forecast period, owing to increased environmental concerns and stricter government restrictions. The emergence of innovative methods for using recycled plastic effectively boosts the polyethylene market's growth.
- Further, the US food and drug administration (FDA) regulates sterilization packaging intended for use in health care under Cfr title 21 880.6850 and classifies it as A class II medical device. Manufacturers must submit A 510(k) outlining the validation testing and results in order to market products. With the adhering to compliance, the market demand for pouches significantly tends to rise in the united states.
- Pharmaceutical pouches are predicted to grow in popularity in the industry due to their numerous advantages. These pouches are preferred by pharmaceutical businesses because they can protect drugs from harmful rays or the environment, and they can be engraved with a prescription.
Asia Pacific Expected to Witness Significant Market Share
- The Asia Pacific Pharmaceutical Market is expected to grow rapidly during the forecasted period. Pharma packaging has been boosted by the constantly developing pharmaceutical industry worldwide. Pharmaceutical packaging is in high demand in densely populated areas such as India and China. Increased pharmaceutical output in these countries has boosted demand even further.
- The region comprises of pharma giants such as China and India, which are prominent providers in the pharmaceutical industry. The home market is predicted to rise thrice in the next decade, according to the Indian Economic Survey 2021. In 2021, India's domestic pharmaceutical market is expected to be worth USD 42 billion, rising to USD 65 billion by 2024 and USD 120-130 billion by 2030.
- During the forecast period, factors such as sustainable packaging, durability, and recyclables, as well as the growing propensity of various end-users such as hospitals and medicine manufacturers, are likely to promote the use of pouches. Due to supply chain interruptions, the prices of essential pharmaceutical ingredients have risen, which is projected to raise the costs of various product types.
- The introduction of stringent laws to enhance the quality and integrity of domestically manufactured drugs has led to an increase in the usage of glass for pharmaceutical packaging solutions. Also, the rising demand for sterile medical packaging products from the industry would further drive the market's growth over the forecast period in the region.
Medical & Pharmaceutical Pouch Industry Overview
The Global Medical & Pharmaceutical Pouch Market is moderately competitive, with a considerable number of regional and global players. Key players include ProAmpac., Glenroy, Inc., Nelipak Corporation, Oliver and Amcor Plc
- June 2022 - At the Med-tech Innovation Expo, Oliver Healthcare Packaging, a leading supplier of pouches, lidding, roll stock, and cleancut mounting cards, demonstrated innovative products. During the sterilization, transportation, and storage operations, their packaging safeguards medical devices and pharmaceutical products.
- June 2021 - Amcor introduced a multi-chamber pouch for drug-device combination items offered for the first time in Europe and has already received a 2021 Award from the Flexible Packaging Association for technological innovation and material structure.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumption and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET INSIGHTS
- 4.1 Market Overview
- 4.2 Porters Five Force Analysis
- 4.2.1 Bargaining Power Of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat Of New Entrants
- 4.2.4 Threat Of Substitutes
- 4.2.5 Intensity of Competitive Rivalry
- 4.3 Assessment of COVID-19 Impact on the Market
5 MARKET DYNAMICS
- 5.1 Market Drivers
- 5.1.1 Growing Need for Lightweight Pouches by Consumers
- 5.1.2 Increasing Spending on Healthcare & Pharmaceutical to Augment the Market Growth
- 5.2 Market Challenges
- 5.2.1 Increasing Raw Material Costs
6 MARKET SEGMENTATION
- 6.1 By Material
- 6.1.1 Polyethylene
- 6.1.2 Polyvinyl Chloride
- 6.1.3 Polypropylene
- 6.1.4 Polyethylene Terephthalate
- 6.1.5 Other Materials
- 6.2 By Product Type
- 6.2.1 Breathable Pouch
- 6.2.2 Tamper Evident Pouch
- 6.2.3 Non-Peelable Pouch
- 6.2.4 High Barrier Pouch
- 6.3 By Application
- 6.3.1 Tablet/Capsule
- 6.3.2 Powder
- 6.3.3 Drug Delivery System
- 6.4 By Geography
- 6.4.1 North America
- 6.4.2 Europe
- 6.4.3 Asia Pacific
- 6.4.4 Latin America
- 6.4.5 Middle East and Africa
7 COMPETITIVE LANDSCAPE
- 7.1 Company Profiles
- 7.1.1 ProAmpac.
- 7.1.2 GFR Pharma Ltd
- 7.1.3 Glenroy, Inc.
- 7.1.4 Nelipak Corporation
- 7.1.5 Oliver
- 7.1.6 Amcor Plc
- 7.1.7 Terrapack
- 7.1.8 American FlexPack
8 INVESTMENT ANALYSIS
9 FUTURE OF THE MARKET